A central priority for Factor-H is ensuring that information about clinical research is shared in a way that does not create unrealistic expectations or add to the emotional burden faced by individuals and families affected by Huntington’s disease. While scientific progress is essential and provides reasons for optimism, it is…

During the third quarter of 2025, Factor-H, in partnership with Hábitat Luz, expanded its impact in the communities of San Luis and Barranquitas, reaching a total of 2,045 people, including individuals with Huntington’s disease (HD), their families, and children from the Abrazos Program.

At first, going to Barranquitas felt like stepping into the world of Mad Max. The heat, the dust, the precariousness, the sense that everything could fall apart at any moment. But over time, something shifted. Maybe it was accepting my mission—to help and inspire. Maybe it was realizing that in…

On July 10, 2024, I wrote a reflection piece following the investor conference where uniQure presented the encouraging 24-month results of AMT-130, the first HTT-directed gene therapy delivered directly into the brain regions most severely affected by mutant huntingtin —the caudate and putamen. At that time, early evidence suggested the…

24/09/2025 Ignacio Muñoz-Sanjuan, neuroscientist and founder of the non-profit Factor-H, has expressed optimism that an experimental gene therapy for Huntington’s disease, developed by uniQure and called AMT-130, could receive regulatory approval in the first half of 2026, in what is a very significant milestone for patients and families affected by…

On July 19, Factor H hosted a Medical Outreach event in San Luis, Venezuela, for people living with Huntington’s disease and those at risk of developing it. More than 100 individuals received comprehensive care—something that would not have been possible without the incredible commitment of 40 volunteers and partners. The…

Santa Marta, 10 de mayo de 2025 En el marco del Programa Abrazos, Factor-H celebró una jornada especial dedicada a los niños y adolescentes afectados directa o indirectamente por la enfermedad de Huntington, bajo el lema "Cuidarte es mi prioridad." La actividad, realizada el 10 de mayo en la ciudad de Santa Marta, se enfocó...

El Día de la Gratitud tuvo lugar el 23 de marzo de 2025 y culminó una semana de eventos en Venezuela para honrar las contribuciones de las familias venezolanas al avance de la ciencia y la medicina. Factor-H, en colaboración con Habitat LUZ, voluntarios de la comunidad y profesionales de la salud, organizó una serie de eventos que...

Factor-H ofrece un servicio de asistencia legal gratuita en Colombia, con el único objetivo de facilitar el acceso a los servicios, medicamentos e insumos que el Estado colombiano asegura a todos los pacientes afectados por la enfermedad de Huntington. Factor-H tiene como objetivo ayudar a todas las familias con EH...

El programa de cuidadores de Factor-H "La Luz" gana el premio Amgen/MIT Solve 2024 en la Cumbre Concordia Nos sentimos muy honrados y agradecidos por este premio, que financiará nuestro programa de apoyo a los cuidadores en Venezuela. El dinero del premio se utilizará para financiar un programa de formación de cuidadores,...